Barinthus Biotherapeutics plc American Depositary Shares Share Price
NASDAQ: BRNS | Micro CapBarinthus Biotherapeutics plc American Depositary Shares Stock Performance
Open $0.72 | Prev. Close $0.75 | Circuit Range N/A |
Day Range $0.72 - $0.75 | Year Range $0.55 - $1.79 | Volume 1,300 |
Average Traded $0.74 |
Barinthus Biotherapeutics plc American Depositary Shares Share Price Today
As of 30 August 2026, Barinthus Biotherapeutics plc American Depositary Shares's share price is $0.75. The stock opened at $0.72, compared to its previous close of $0.75. During today's trading session, Barinthus Biotherapeutics plc American Depositary Shares's share price traded between $0.72 and $0.75, with an average price of $0.74. Over the past 52 weeks, the stock has recorded a high of $1.79 and a low of $0.55. In terms of performance, Barinthus Biotherapeutics plc American Depositary Shares's share price has risen by 23.37% over the last six months and is down 39.81% on a year-on-year basis.
Barinthus Biotherapeutics plc American Depositary Shares Share Price Chart
Barinthus Biotherapeutics plc American Depositary Shares Stock Fundamentals & Key Indicators
Market Cap $30.25M | PE Ratio (TTM) -0.46 | Dividend Yield N/A |
EPS (TTM) $-1.64 | Revenue (TTM) N/A | Return On Equity (TTM) -89.56% |
Profit Margin N/A | Debt to Equity 0.13 | Quarterly Earnings Growth YoY 14.00% |
Barinthus Biotherapeutics plc American Depositary Shares Quarterly Profit & Loss
All figures in USD
Barinthus Biotherapeutics plc American Depositary Shares Annual Profit & Loss
All figures in USD
About Barinthus Biotherapeutics plc American Depositary Shares
Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapeutic drug candidates for treating auto-immune and inflammatory diseases. Its lead candidate is VTP-1000, which is in Phase 1 clinical trial to restore immune non-responsiveness to gluten in patients with celiac disease. The company is also developing VTP-300, an immunotherapeutic targeting chronic hepatitis B virus infection; VTP-200, a potential non-invasive treatment for persistent high-risk human papillomavirus; VTP-850, an immunotherapeutic candidate for prostate cancer; VTP-600, an immunotherapeutic candidate targeting MAGE-A3 and NY-ESO1 antigens; VTP-500, a prophylactic vaccine candidate to prevent middle east respiratory syndrome; VTP-400, a prophylactic vaccine candidate for shingles; and Vaxzevria, a prophylactic vaccine for the prevention of COVID-19 infection. The company was formerly known as Vaccitech plc and changed its name to Barinthus Biotherapeutics plc in November 2023. Barinthus Biotherapeutics plc was founded in 2016 and is headquartered in Didcot, the United Kingdom.
Barinthus Biotherapeutics plc American Depositary Shares Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $0.59 | $0.75 | +23.76% |
Jul 2026 | $0.66 | $0.61 | -10.22% |
Jun 2026 | $0.68 | $0.68 | -3.57% |
May 2026 | $0.65 | $0.70 | +15.13% |
Apr 2026 | $0.62 | $0.61 | +10.55% |
Mar 2026 | $0.58 | $0.55 | -9.09% |
Feb 2026 | $0.71 | $0.60 | -15.97% |
Jan 2026 | $0.71 | $0.72 | +4.20% |
Dec 2025 | $0.75 | $0.69 | -4.03% |
Nov 2025 | $1.22 | $0.72 | -45.04% |
Oct 2025 | $1.47 | $1.31 | +7.38% |
Sep 2025 | $1.19 | $1.22 | -1.61% |
BRNS Share Price FAQs
What is Barinthus Biotherapeutics plc American Depositary Shares share price today?
What is the 52 week high and 52 week low of Barinthus Biotherapeutics plc American Depositary Shares stock?
What is BRNS's market capitalisation today?
What is BRNS's net income for the last quarter?
What is the 5 year returns of BRNS?
What is the high & low stock price of BRNS today?
Can I buy BRNS shares in India?